Navigation Links
ash in Medical News

"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition

LONDON, March 11 /PRNewswire/ -- - With Photo To mark this year's No Smoking Day, three 'mini' entrepreneurs today went head-to-head to win a GBP2,000 investment from TV Dragon Duncan Bannatyne. In a re-enactment of the TV challenge, the school children faced their toughest chall...

REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting

Mountain View, CA December 5, 2008 REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders, will present preclinical data on the company's potential therapeutic treatment for Graft versus Host Disease (GvHD) at the Am...

Zevalin Data to be Presented at ASH 2008

SEATTLE, Dec. 4 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced presentations or posters of interest related to Zevalin(R) (ibritumomab tiuxetan) to be presented at the 50th Annual Meeting of the American Society of Hematology (ASH), December 5-9, 200...

Horse Drawn Hearse and Ash Scattering by Balloon - Hello LAFuneralGuide.com!

First-ever Online Funeral Planning Guide for Los Angeles SEATTLE, Nov. 11 /PRNewswire/ -- Brides planning a wedding have over eight online wedding guides to help them explore ideas and connect with local Los Angeles vendors. On the other hand, families planning a funeral have none -- u...

Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting

Initial Physician Experience with Eculizumab in Patients with Other Rare Complement-Mediated Diseases also to be Presented CHESHIRE, Conn., Nov. 10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced that the American Society of Hematology (ASH) has publi...

CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

- Conference call to be hosted on Tuesday, December 11th at 9:00 a.m. Eastern time - - Encouraging clinical results presented at ASH from the ongoing Phase II trial in T-cell lymphomas - - Positive End-of-Phase II meeting held with the FDA for b...

Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting

SOUTH SAN FRANCISCO, Calif., Dec. 6 /PRNewswire/ -- Proteolix, Inc. announced today that data from two Phase 1 clinical studies using intravenous carfilzomib (PR-171) are to be presented at the 2007 American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia, December 8-10, 2007. C...

Kiadis Pharma Presents ATIR and Rhitol Data at ASH and NIH Presentation on ATIR at ASH

AMSTERDAM, November 23 /PRNewswire/ -- Kiadis Pharma announces today that there will be three presentations on its products ATIR and Rhitol in poster sessions at the 2007 Annual Meeting of the American Society of Hematology (ASH) December 8-11 in Atlanta, Georgia, USA. Data will be presented f...

Chilean volcano captured blasting ash

Chiles Chaiten Volcano is shown spewing ash and smoke (centre left of image) into the air for hundreds of km over Argentinas Patagonia Plateau in this Envisat image acquired on 5 May 2008. The 1000 m-high volcano had been dormant for thousands of years before erupting on 2 May, causing the evac...

HVO Launches Hematology Program in Uganda in Partnership with ASH

WASHINGTON, March 28 /PRNewswire-USNewswire/ -- Health Volunteers Overseas (HVO) and the American Society of Hematology (ASH) are pleased to announce the establishment of the first HVO hematology training program, at Mulago Hospital located in Kampala, Uganda. Mulago Hospital is a 1500-bed fac...

More>>

ash in Medical Technology

First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting

CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), was associated with an improvement in hematologic parameters in a l...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

- Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH - Exjade results at ASH to show benefits for chronically transfused patients by significantly reducing toxic iron that can dama...

TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients

SAN DIEGO, Dec. 1 /PRNewswire/ -- TargeGen has announced that an oral presentation of preliminary results from a multi-center, US-based clinical trial of TG101348 in myeloproliferative disease patients has been scheduled at the 2008 American Society of Hematology (ASH) Meeting. Details o...

Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma

BIRMINGHAM, Ala., Dec. 14 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today reported clinical trial and in vitro data evaluating forodesine HCl, the Company's lead anti-cancer compound, in the treatment of certain types of leukemias and lymphomas. Madeline Duvic...

ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients

WASHINGTON, Oct. 22 /PRNewswire-USNewswire/ -- Today, the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) have released an updated joint guideline on the use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow t...

Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH

-- Conference Call Scheduled for Tuesday, December 9 at 11:00 am ET to Discuss Phase 2 Study Results in AML -- SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and comme...

Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash

HAYWARD, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN ) presented updated data from a dose-escalating Phase 1b clinical trial of Hsp90 inhibitor tanespimycin (KOS-953) in combination with bortezomib (Velcade(R)), showing durable antitumor activity and ...

TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH

SAN DIEGO, Dec. 6 /PRNewswire/ -- TargeGen, Inc. today announced that the Company's recently submitted IND for TG101348 is now active and the Company plans to initiate a multi-center clinical trial of TG101348, an internally discovered, oral, potent, and highly selective JAK2 inhibitor in Janu...

Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy

Data Also Show Nebivolol Lowers Blood Pressure in Obese and Non-Obese Hypertensive Patients CHICAGO, May 21, 2007 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. today presented positive data from two clinical studies and one pooled analysis of nebivolol, a selective beta 1-blocker with vasodi...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

...e, Anthony W. Opipari, Mack T. Ruffin, IV, Linda M. Kalikin, and David M. Kurnit. This work was supported in part by grants from the Mary Kay ash Charitable Foundation (DMK), SensiGen, LLC (DMK), and the National Cancer Institute of the National Institutes of Health [K24 CA080846 (MTR), K07 CA12...

More>>

ash in Biological News

Emerald Spectre haunts Ontario's ash forests

A new study shows that while we're winning isolated battles, we could well lose the war to prevent the devastating spread of the emerald ash borer in eastern Canada and the United States. It's a failure that would cost billions of dollars in lost timber and ornamental trees, and dramatically change...

August 2009 Geology and GSA Today media highlights

...frica. By analyzing and dating 205 zircon grains extracted from deep-marine ash beds of the western Karoo (using an high-resolution microprobe [SHRIMP-RG] ...the recovery of late Pleistocene mammal fossils. By using numerous volcanic ash beds that characterize the fossil-rich strata to determine the age and corr...

Global sunscreen won't save corals

...he upper atmosphere. This would partially block incoming sunlight before it reached the Earth's surface, lowering global temperatures just as volcanic ash from the Mount Pinatubo did following its eruption in 1991. But critics have warned that such a scheme might also alter rainfall patterns, damage the ...

CU-Boulder study shows Maya intensively cultivated manioc 1,400 years ago

...uried and exquisitely preserved under a blanket of ash by a volcanic eruption in present-day El Salvador ...jacent to Ceren, which was buried under 17 feet of ash and is considered the best preserved ancient farmi...oc," said Sheets, who discovered Ceren in 1978. ash hollows in the manioc planting beds at Ceren left ...

Fossil bone bed helps reconstruct life along California's ancient coastline

...uvenile specimens, the team also discounted the hypothesis that this was a breeding ground for early seals such as Allodesmus. The absence of volcanic ash makes a volcanic catastrophe unlikely, while the presence of land mammal fossils makes red tide an unlikely cause. "These animals were dying over t...

Study compares sound from exploding volcanoes with jet engines

.... Large-amplitude infrasonic signals from volcanic eruptions are currently used in a prototype real-time warning system that informs the Volcanic ash Advisory Center (VAAC) when large infrasonic signals have come from erupting volcanoes. Researchers hope this new information can improve hazard mitig...

April 2009 Geology and GSA Today media highlights

...anism can have significant environmental impact because of the discharge of ash and volatiles directly into the atmosphere and oceans. Jicha et al. compile...basalts had lesser effects on the biosphere. The cooling effect of volcanic ash and sulphate aerosols injected into the stratosphere during Plinian eruptio...

European satellites provide new insight into ozone-depleting species

...easured by a space instrument. In August 2008, the Kasatochi Volcano in Alaska's Aleutian Islands erupted explosively, sending a cloud of volcanic ash and gas more than 11 km into the atmosphere. The following day, scientists from the Brussels-based Belgian Institute for Space Aeronomy identified...

January-February GSA Bulletin media highlights

...ither intrusively through inflation or extrusively through lava flow and/or ash fall emplacement. Higher heat flow during Noachian time, or geothermal heat... similar to the modern boreal forest of central Alaska. Associated volcanic ash beds suggest that this buried forest bed is about two million years old, so...

Urban trees enhance water infiltration

...ds and simultaneously provide rooting space for trees. In this study, green ash trees increased the average infiltration rate by 27 fold compared with unpl...6 g cm‑3) by a woven geotextile in 102-liter containers. The roots of ash trees planted in the structural soil penetrated both the geotextile and the...

More>>

ash in Biological Technology

Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias

Interim Data from a Phase 2 Clinical Trial in B-Precursor Acute Lymphoblastic Leukemia Show that Blinatumomab is Able to Eliminate Minimal Residual Disease BETHESDA, Md., Dec. 8 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, propr...

Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting

Company Introduces New Trade Name Onrigin(TM) for Laromustine NEW HAVEN, Conn., Dec. 4 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today made several announcements related to events in connection with the 50th American Society of Hematology Annua...

Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting

MONTREAL, Nov. 25 /PRNewswire/ - Aegera Therapeutics Inc. today announced that data from its phase 1/2 clinical trial of the XIAP antisense oligonucleotide, AEG35156, will be highlighted in an oral presentation at the 50th Annual Meeting of the American Society of Hematology (ASH) in San Francisco...

Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH

SOUTH SAN FRANCISCO, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that members of Rigel's senior management team will host a conference call with simultaneous webcast on Sunday, December 7, 2008, at 4:00 p.m. PST, to discuss the results of ...

Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH

Responses Significantly Correlated to Overall Survival Summary: Three ofatumumab Abstracts Have Been Accepted for Presentation at the ASH Meeting December 6-9, 2008 COPENHAGEN, November 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today that three of...

AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer

...ine is dosed 50mg or 100mg daily until progression. Recently, positive Phase 2 data for multiple myeloma and metastatic colon cancer were presented at ash and ASCO meeting, respectively." About Perifosine Perifosine is a novel, first-in-class, oral anti-cancer agent that modulates several key s...

Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies

...he immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September, ash launched Blood: The Vital Connection ( www.bloodthevitalconnection.org ), a credible online resource addressing bleeding and clotting disorders,...

Just Say No To Charcoal! New Eco-Friendly Alternative Grills Faster, Burns Cleaner And Greener

...east. While the FlameDisk heat output is similar to charcoal, it creates no ash or soot, meaning there's no messy cleanup. After the solid ethanol fuel bur...inutes --much faster than charcoal, which can take hours to cool before the ash can be safely disposed. This ability to cool off rapidly gives FlameDisk gr...

BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update

...evere chronic plaque psoriasis. Results showed BCX-4208 was safe and well tolerated. BioCryst also presented a poster at ash entitled, "BCX-4208 (RO5092888), a Purine Nucleoside Phosphorylase (PNP) Inhibitor is a Novel, Potent Orally Active Anti T- and B-Cell Agent." Findin...

Sunesis Pharmaceuticals Provides Year-End Clinical Update on Voreloxin

...t that Schedule B is better tolerated by patients, while maintaining anti-leukemic activity. New data on the 21 patients on Schedule B reported on at ash indicate 6 have achieved a CR or CRp, while 2 are awaiting hematologic count recovery. In addition to improved tolerability, the 30-day all-cause mor...

More>>

ash in Biological Dictionary

Clones

...l rooms, vacations, and rental cars with Kayak.com. Search hundreds of travel sites, compare results, and buy direct. Watch Clones music video by ash now at Yahoo! Music. Access free music videos, song lyrics, online radio and music downloads. ...
Other Tags
(Date:8/3/2015)... ... August 03, 2015 , ... Constantin Vasilica, 48 from Romania wanted ... caused by diabetes after many years of suffering and using medications with strong side ... want to ask for extra time off or wait longer hours in the waiting ...
(Date:8/3/2015)... , ... August 03, 2015 ... ... a leading provider of medical information, risk management and investigative services, has ... and direction toward focused, expert information solutions that improve business outcomes for ...
(Date:8/3/2015)... ... August 03, 2015 , ... Recent reports by the American ... at least once in their lives. Often time, low back and sciatic pain can ... could only be managed clinically with powerful pain medication or spinal surgery. Dynamic ...
(Date:8/2/2015)... (PRWEB) , ... August 03, 2015 , ... For many “would be” entrepreneurs, starting ... get help” or “I can’t afford to start a business.” Neither needs be a major ... right and theoretical opportunity to start a business and be successful. The risks of starting ...
(Date:8/1/2015)... ... August 02, 2015 , ... AlignLife Office Coordinator Heather ... continuity of care for patients at this natural health care center in Winamac. , ... Mary Heal said. "Heather's role is vital to our approach because we want to ...
Breaking Medicine News(10 mins):Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:New Patient Advocate Enhances Natural Health Care 2
(Date:7/21/2015)... , July 21, 2015 Today, ZTE announced ... received as well as expected revenues in 2015 that relate to ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ... a leading smartphone manufacturer in China and ... 02 5 for Axon , ...
(Date:7/13/2015)... JOSE, Calif. , July 13, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... generation touch and display driver integration (TDDI) product ... is the first to combine Synaptics , ... with proven display driver technology developed in the ...
(Date:7/9/2015)... , July 9, 2015  Unchained Labs just ... its acquisition of Avid Nano. Avid Nano designs, ... (DLS) systems.    Also today, Unchained ... and easiest to use protein sizing system. The ... a protein,s hydrodynamic size, size distribution, aggregation population ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
Other Contents